The therapeutic potential of proteinase-activated receptors in arthritis

Current Opinion in Pharmacology

Volumn 7, Issue 3, 2007, Pages 334-338

  McIntosh, Kathryn A ^a,b   Plevin, Robin ^a   Ferrell, William R ^c   Lockhart, John C ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENMD 1068; FIBROBLAST GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; PEPTIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PROTEINASE ACTIVATED RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; RECEPTOR BLOCKING AGENT; RWJ 58259; SCH 203099; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CARTILAGE CELL; CELL PROTECTION; CHRONIC INFLAMMATION; EVIDENCE BASED MEDICINE; HUMAN; IN VIVO STUDY; MEDICAL RESEARCH; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ARTHRITIS; HUMANS; JOINTS; RECEPTOR, PAR-2;

EID: 34248377840     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.01.002     Document Type: Review

References (40)

1. Macfarlane S.R., Seatter M.J., Kanke T., Hunter G.D., and Plevin R. Proteinase- activated receptors. Pharmacol Rev 53 (2001) 245-282
2. Vu T.K.H., Hung D.T., Wheaton V.I., and Coughlin S.R. Molecular-cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 (1991) 1057-1068
3. Scarborough R.M., Naughton M.A., Teng W., Hung D.T., Rose J., and Vu T.K.H. Tethered ligand agonist peptides - structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267 (1992) 13146-13149
4. Nose T., Shimohigashi Y., Ohno M., Costa T., Shimizu N., and Ogino Y. Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine. Biochem Biophys Res Commun 193 (1993) 694-699
5. Feng D.M., Veber D.F., Connolly T.M., Condra C., Tang M.J., and Nutt R.F. Development of a potent thrombin receptor ligand. J Med Chem 38 (1995) 4125-4130
6. Andrade-Gordon P., Derian C.K., Maryanoff B.E., Zhang H.C., Addo M.F., Cheung W., Damiano B.P., D'andrea M.R., Darrow A.L., Garavilla L., et al. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther 298 (2001) 34-42
7. Ahn H.S., Foster C., Boykow G., Stamford A., Manna M., and Graziano M. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{4- (1-methylethyl) phenylmethyl}-7H-pyrrolo-3, 2-f quinazoline-1, 3-diamine (SCH 79797), a non-peptide thrombin receptor antagonist. Biochem Pharmacol 60 (2000) 1425-1434
8. Ferrell W.R., Lockhart J.C., Kelso E.B., Dunning L., Plevin R., Meek S.E., Smith A.J.H., Hunter G.D., McLean J.S., McGarry F., et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111 (2003) 35-41
9. Kawabata A., Kanke T., Yonezawa D., Ishiki T., Saka M., Kabeya M., Sekiguchi F., Kubo S., Kuroda R., Iwaki M., et al. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 309 (2004) 1098-1107
10. Kelso E.B., Lockhart J.C., Hembrough T., Dunning L., Plevin R., Hollenberg M.D., Sommerhoff C.P., McLean J.S., and Ferrell W.R. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316 (2006) 1017-1024. The authors of this paper are the first to demonstrate the use of a novel PAR-2 antagonist.
11. Hollenberg M.D., and Saifeddine M. Proteinase-activated receptor-4 (PAR- 4): activation and inhibition of rat platelet aggregation by PAR-4 derived peptides. Canadian J Phys & Pharm 79 (2001) 439-442
12. Ishihara H., Connolly A.J., Zeng D., Kahn M.L., Zheng Y.W., Timmons C., Tram T., and Coughlin S.R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386 (1997) 502-506
13. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors - contribution to physiology and disease. Physiol Rev 84 (2004) 579-621
14. Shpacovitch V.M., Brzoska T., Buddenkotte J., Stroh C., Sommerhoff C.P., Ansel J.C., Schulze-Osthoff K., Bunnett N.W., Luger T.A., and Steinhoff M. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor κB in human dermal microvascular endothelial cells. J Invest Dermatol 118 (2002) 380-385
15. Howells G.L., Macey M.G., Chinni C., Hou1 L., Fox M.T., Harriott P., and Stone S.R. Proteinase-activated receptor 2: expression by human neutrophils. J Cell Sci 110 (1997) 881-887
16. Mari B., Guerin S., Far D.F., Breitmayer J.P., Belhacene N., Peyron J.F., Rossi B., and Auberger P. Thrombin and trypsin-induced Ca (2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J 10 (1996) 309-316
17. Cenac N., Coelho A.M., Nguyen C., Compton S., Andrade-Gordon P., MacNaughton W.K., Wallace J.L., Hollenberg M.D., Bunnett N.W., Garcia- Villar R., et al. Induction of Intestinal inflammation in mouse by activation of Proteinase-Activated receptor 2. Am J Pathol 161 (2002) 1903-1914
18. Nystedt S., Ramakrishnan V., and Sundelin J. The proteinase-activated receptor-2 is induced by inflammatory mediators in human endothelial cells - Comparison with the thrombin receptor. J Biol Chem 271 (1996) 14910-14915
19. Noorbakhsh F., Vergnolle N., McArthur J.C., Silva C., Vodjgani M., Andrade- Gordon P., Hollenberg M.D., and Power C. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol 174 (2005) 7320-7329. The authors demonstrate that, in HIV-associated dementia, the pro-inflammatory cytokines tumour necrosis factor-α and interleukin-1β induce PAR-2 expression.
20. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., Trevisani M., Hollenberg M.D., Wallace J.L., Caughey G.H., et al. Agonists of proteinase-activated receptor-2 induce inflammation by a neurogenic mechanism. Nat Med 6 (2000) 151-158
21. Sato K., Ninomiya H., Ohkura S., Ozaki H., and Nasu T. Impairment of PAR- 2-mediated relaxation system in colonic smooth muscle after intestinal inflammation. Br J Pharmacol 148 (2006) 200-207
22. Cocks T.M., Fong B., Chow J.M., Anderson G.P., Frauman A.G., Goldie R.G., Henry P.J., Carr M.J., Hamilton J.R., and Moffatt J.D. A protective role for protease-activated receptors in the airways. Nature 398 (1999) 156-160
23. Cattaruzza F., Cenac N., Barocelli E., Impicciatore M., Hyun E., Vergnolle N., and Sternini C. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol 169 (2006) 177-188
24. Choy E.H.S., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344 (2001) 907-916
25. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
26. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44 (2001) 1237-1247
27. Marty I., Péclat V., Kirdaite G., Salvi R., So A., and Busso N. Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest 107 (2001) 631-640
28. Morris R., Winyard P.G., Brass L.F., Blake D.R., and Morris C.J. Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue. Ann Rheum Dis 55 (1996) 841-843
29. Fields R.C., Schoenecker J.G., Hart J.P., Hoffmman M.R., Pizzo S.V., and Lawson J.H. Protease-activated receptor 2 signaling triggers dendritic cell development. Am J Pathol 162 (2003) 1817-1822
30. Kelso EB, Ferrell WR, Lockhart JC, Elias-Jones I, Hembrough T, Dunning L, Gracie A, McInnes IB: Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium. Arthritis Rheum 2007, in press. The authors identify PAR-2 as a novel upstream regulator of pro-inflammatory cytokine production in RA.
31. Abe K., Aslam A., Walls A.F., Sato T., and Inoue H. Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts. Life Sci 79 (2006) 898-904. Highlights a role for basic fibroblast growth factor in the regulation of functional PAR-2 expression in culture RA fibroblasts.
32. Xiang Y., Masuko-Hongo K., Sekine T., Nakamura H., Yudoh K., Nishioka K., and Kato T. Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β. Osteoarthritis Cartilage 14 (2006) 1163-1173. First paper to concentrate on chondrocytes and PAR-2 in the context of arthritis.
33. Buckley M.G., Walters C., Wong W.M., Cawley M.I., Ren S., Schwartz L.B., and Walls A.F. Mast cell activation in arthritis. Detection of α and β tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 93 (1997) 363-370
34. Nakano S., Ikata T., Kinoshita I., Kanematsu J., and Yasuoka S. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 17 (1999) 161-170
35. Uehara A., Muramoto K., Takada H., and Sugawara S. Neutrophil serine proteinases activate human non-epithelial cells to produce inflammatory cytokines through proteinase-activated receptor 2. J Immunol 170 (2003) 5690-5696
36. Kawabata A., Kuroda R., Minami T., Kataoka K., and Taneda M. Increased vascular permeability by a specific agonist of proteinase-activated receptor-2 in rat hindpaw. Br J Pharmacol 125 (1998) 419-422
37. Busso N., Frasnelli M., Feifel R., Cenni B., Steinhoff M., Hamilton J., and So A. Evaluation of protease-activated receptor 2 in murine models of arthritis. Arthritis Rheum 56 (2007) 101-107. Examines PAR-2 in an immune context with regard to inflammatory arthritis.
38. Yang Y.H., Hall P., Little C.B., Fosang A.J., Milenkovski G., Santos L., Xue J., Tipping P., and Morland E. Reduction of arthritis severity in protease-activated receptor-deficient mice. Arthritis Rheum 52 (2005) 1325-1332. Demonstrates the requirement of PAR-1 for an antigen-induced arthritis response, for the development of an antigen-specific Ig response, and for cytokine and MMP expression in macrophages.
39. Ivashkiv L.B. Cytokine expression and cell activation in inflammatory arthritis. Adv Immunol 63 (1996) 337-376
40. Manabe N., Oda H., Nakamura K., Kuga Y., Uchida S., and Kawaguchi H. Involvement of fibroblast growth factor 2 in joint destruction of rheumatoid arthritis patients. Rheumatology (Oxford) 38 (1999) 714-720